For more information about our Gynecologic Cancer program, call
980-442-2000 or 800-804-9376.
After a gynecologic cancer diagnosis, our ovarian cancer team formulates a multidisciplinary treatment plan for each patient after the initial consultation with one of the gynecologic oncologists. Women requiring hospitalization are cared for in a specialized nursing unit in Carolinas Medical Center.
Most gynecologic cancers require a multifaceted treatment approach. These may include electrocoagulation therapy or laser ablation for pre-invasive cancer of the cervix, as well as surgery, radiation and/or chemotherapy for more advanced types of gynecologic cancer (inclusive of vaccines, biologics and intraperitoneal chemotherapy).
The Gynecologic Oncology Program participates in research through the Gynecologic Oncology Group (GOG) of which we are one of the national primary research sites, which is sponsored by the National Cancer Institute. A number of investigator-initiated studies are also available, which are unique to Blumenthal Cancer Center. Other innovative and cutting-edge chemotherapy regimens are available through relationships with major pharmaceutical oncology divisions.
According to program Director James B. Hall, MD, "Sixty-five percent to 70 percent of women with ovarian cancer are diagnosed at stage III."
Therefore, the Gynecologic Oncology Program places a major emphasis on patient education and risk assessment. An ovarian cancer risk assessment is available to women who are concerned that they may be at risk for ovarian cancer due to family history of ovarian or breast cancer.
The Cancer Risk Assessment Program is a joint program between Levine Cancer Center and the Clinical Genetics Program. A carefully chosen team of physicians, genetic counselors, nurses and support counselors assist patients, their families, and referring physicians regarding cancer risk factors and recommendations for care.
Communication with patients and caregivers is an important priority at Blumenthal Cancer Center. We believe that treating the whole person, not just the disease, is best for patients and family members. At Blumenthal Cancer Center, we offer a broad range of emotional support programs designed to help patients and family members cope with the range of issues related to life during and after cancer treatment.
The Carolinas Ovarian Cancer Fund was established in 1998. This fund supports basic research in ovarian cancer and cervical cancer at the Cannon Research Center of Carolinas Medical Center. For more information, contact the Carolinas Healthcare Foundation at 704-355-4048.
For more information about Levine Cancer Institute, including referrals, call 980-442-2000 or 800-804-9376.